To test our hypothesis that HA is a key molecule that drives inflammation in the gut during intestinal inflammation, we treated mice that were null for either HAS1 or HAS3 or both HAS1/HAS3 in the experimental DSS-colitis model. Here, HAS1 is linked to inflammation.